- Oral contraceptives, vitamin supplements and calcium can be helpful.
- Selected antidepressants can be used a first line of treatment.
- Acupuncture and herbal medicines have insufficient evidence.
Latest Updates
- Oral contraceptives, vitamin supplements and calcium can be helpful.
- Selected antidepressants can be used a first line of treatment.
- Acupuncture and herbal medicines have insufficient evidence.
- Oral contraceptives, vitamin supplements and calcium can be helpful.
- Selected antidepressants can be used a first line of treatment.
- Acupuncture and herbal medicines have insufficient evidence.
Human Papillomavirus Infection and Prevention In The Adolescent
- HPV infection of certain high-risk oncotypes with viral persistence is thought to be necessary for development of serious dysplasia and cancer. HPV can enter a latent state and be reactivated at a later time.
- The alarming rise in oropharyngeal cancers has been attributed to oncogenic HPV types previously only recognized for causing cervical cancer; adolescents who participate in noncoital sexual activity may be at higher risk than previously thought.
- The HPV vaccine has proven to be safe and effective, and the inclusion of nine serotypes of HPV in the latest vaccine provides the most coverage against oncogenic subtypes to date.
- Both boys and girls should be vaccinated against HPV at a target age of 11–12 years, but may receive the vaccination as early as 9 or as late as 26 years old. There is a revision of the vaccination schedule to require only two in the series if it is given prior to the age of 15.
- Large decreases in HPV infection have been seen in past 10 years after vaccination has been available.
Stress Urinary Incontinence I: Nonsurgical Management
- urethral bulking agents – stem cells used for urethral bulking in trials
- 2014 ACP Practice Guidelines: Nonsurgical Management of Urinary Incontinence in Women
- 2018 SOGC Practice Guidelines: Evaluation of Stress Incontinence Prior to Primary Surgery
- 2017 SOGC Practice Guidelines: Management of Recurrent Urinary Incontinence After Pelvic Floor Surgery
- Polidocanol is now FDA approved in a foam formulation
- Correction of axial great spahenous vein reflux first is essential for optimal success of venous sclerotherapy treatments
- Venous duplex ultrasonography has revolutionized the treatment of varicose and spider veins.
- Sclerotherapy is reproducible and noninvasive and can objectively identify areas of reflux in the great and small saphenous systems, as well as detect pathologic conditions in the deep venous system and incompetent perforating vessels. Sclerosants may be classified into three main categories: hypertonic solutions, chemical irritants, and detergents.
- The detergent class of sclerosants form aggregates on endothelial cell surfaces and cause endofibrosis by disrupting the integrity of the cells. Polidocanol (POL) is the most commonly used sclerotherapy agent worldwide. Sodium tetradecyl sulfate (STS) is also a commonly used agent in the United States; both POL and STS are approved by the FDA.
Primary and Preventive Care of Women
- Latest USPSTF recommendation on breast cancer screening
- Latest USPSTF recommendation guide to clinical preventive services
- Latest USPS evidence review on aspirin for the primary prevention of cardiovascular events
- Latest USPSTF recommendations for use of antiretroviral drugs in pregnant HIV-infected women
- Latest NOF clinician guide to prevention and treatment of osteoporosis
- Latest ACS guideline for breast cancer screening for women at average risk
Primary and Preventive Care of Women
- Latest USPSTF recommendation on breast cancer screening
- Latest USPSTF recommendation guide to clinical preventive services
- Latest USPS evidence review on aspirin for the primary prevention of cardiovascular events
- Latest USPSTF recommendations for use of antiretroviral drugs in pregnant HIV-infected women
- Latest NOF clinician guide to prevention and treatment of osteoporosis
- Latest ACS guideline for breast cancer screening for women at average risk
